The U.S. Food and Drug Administration announced a series of steps to increase the supply of critically needed cancer drugs and build on President Obama's Executive Order to help prevent future drug shortages.

February 22, 2012 -- Hutchison MediPharma, the drug discovery company majority owned by Chi-Med, began a first-in-human Phase I clinical trial of a cancer drug, volitinib (HMPL-504), in Australia. Volitinib, the fourth cancer drug candidate that the company has put into clinical trials, is a novel inhibitor of the c-Met receptor tyrosine kinase. In December 2011, Hutchison MediPharma entered a co...

CARMIEL, Israel, Feb. 22, 2012 (GLOBE NEWSWIRE) -- ProtalixBioTherapeutics, Inc. (NYSE-AMEX:PLX) (TASE:PLX), announced today theclosing of its previously announced underwritten public offering. Priorto the closing, the underwriters exercised, in full, theirover-allotment option to purchase an additional 675,000 shares ofcommon stock. As a result, the Company sold a total of 5,175,000 shares...

San Rafael, CA February 21, 2012: BNC Scientific, the exclusive North American partner for Zurich Instruments is proud to carry the fastest commercial lock-in amplifier (LIA) ever commercially produced. Zurich Instruments, the technology leader for lock-in amplifiers, has developed the UHFLI (Ultra-High Frequency Lock-in Amplifier), establishing a precedent in LIAs. The UHFLI performs measurements...

February 22, 2012 -- Air Science USA has introduced a NEW Advanced range of Ductless Fume Hoods with sophisticated airflow, filter alarms and advanced safety features. These units are available from 2 to 8 feet.

These fume hoods have been designed to provide maximum operator protection when using hazardous substances.A face velocity at 100 fpm ensures containment of fumes and an alarm will...

BURLINGTON, Mass., Feb. 22, 2012 (GLOBE NEWSWIRE) -- CoronadoBiosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused onthe development of novel immunotherapy agents for the treatment ofautoimmune diseases and cancer, today announced that Lucy Lu, M.D. hasjoined the Company as Executive Vice President and Chief FinancialOfficer. Mr. Dale Ritter, current acting Chief Financial...

Edison, NJ - February 22, 2012 - (http://www.escortdataloggers.com) -- Escort, leader in data logger systems that offer an extensive range of temperature and humidity, has recently hired an additional inside sales representative, Cira Costa, to join their team.

"We have seen the industry grow in recent years and this prompted the need for an additional inside sales representative. Cira...

February, 2012 -- After a sizable drop in third quarter hiring, the ZRG Partners Global Life Sciences Hiring Index returned to growth, ending the year at a 76.11 mark. The year was a stable growth year in overall hiring with an average increase of 14% year over year.

The Outsourcing and Services sector was the clear story in the quarter, with a 39% increase in new jobs over Q3. The sector...

Waltham, MA The Massachusetts Life Sciences Center announced today that the Centers Board of Directors has awarded $21.2 million in tax incentives to 28 life sciences companies. The recipient companies have committed to creating more than 940 new jobs in the Commonwealth this year.

The Life Sciences Tax Incentive Program, established in 2008 as part of the states ten-year, $1 billion...

SANTA CLARA, Calif., Feb. 22, 2012 Agilent Technologies Inc. (NYSE: A) announced today that it will be hosting the Agilent Science and Technology Symposium 2012 in multiple phases. ASTS will include an online symposium on Feb. 29, followed by a mobile trade show, March 20-June 12. The mobile trade show will visit 16 cities in North America and six in Latin America.

Online Event

...

SALT LAKE CITY, Feb. 22, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.(Nasdaq:MYGN) announced today that Mark Capone, President, MyriadGenetic Laboratories, Inc., is scheduled to present at the Cowen andCompany 32nd Annual Health Care Conference, at 8:00 a.m. Eastern Timeon Tuesday, March 6, 2012. The conference is being held at The BostonMarriott Copley Place Hotel in Boston, Massachusetts...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo pathology, today announced that the company has initiated a clinical trial to evaluate high-resolution optical imaging of Barretts esophagus using its proprietary Nvision VLE Imaging System, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA...

BRUSSELS, Feb. 22, 2012 /PRNewswire/ -- UCB today announced the start of C-EARLY a phase III study that will evaluate the efficacy and safety of Cimzia (certolizumab pegol) in combination with methotrexate (MTX) for inducing and sustaining clinical response in adults with early, progressive, active, moderate...

Increased Awareness Among Clinicians and Parents Could Lead to Earlier Diagnosis and Intervention for Minority Children with ASD

BALTIMORE, Feb. 21, 2012 /PRNewswire-USNewswire/ -- The first prospective study of ethnic differences in the symptoms of autism in toddlers shows...

NEW ORLEANS, Feb. 21, 2012 /PRNewswire-USNewswire/ -- New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people. The research was released today and will be presented at the

BLUE BELL, Pa., Feb. 22, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that its next generation surface skin electroporation technology was successfully used to significantly enhance the delivery of small interfering RNA (siRNA) molecules to skin in animal studies. The data...

Hamburg and Munich, Germany, February 22, 2012 / B3C newswire / - apceth GmbH & Co. KG, located in Munich, Germany, and Indivumed GmbH, based in Hamburg, Germany, have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics. The goal is to predict the response of a targeted cellular...

MONROVIA, Calif. and INGELHEIM, Germany, Feb. 21, 2012 /PRNewswire/ -- Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for...

PLEASANTON, Calif., Feb. 22, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Life Technologies Corporation (LTC) announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

Under these two agreements, Roche has granted...

MERIDEN, Conn., Feb. 22, 2012 /PRNewswire/ -- Protein Sciences Corporation ("Protein Sciences") announced today that it has granted Merck, through a subsidiary, a non-exclusive license to Protein Sciences' proprietary expresSF serum-free insect cell line (SF) and related technology (collectively, PS Technology...